According to a new report, the global cancer diagnostics market is
anticipated to grow at 8.9% CAGR during the forecast period
2016-2026. The market was valued at over US$ 32 Bn in 2016, and it
expected to surpass US$ 76 Bn in revenues by 2026.
By test type, the global cancer diagnostics market has been segmented
into tumour biomarker tests, imaging, biopsy, liquid biopsy,
immunohistochemistry, and in situ hybridisation. Among these,
biopsy/tissue diagnostics is the largest segment by test type,
accounting for 36% revenue share. In terms of revenues, the global
market was valued at US$ 11.76 Bn in 2016.
By end-user, key segments include cancer research institutes,
diagnostic imaging centers, independent diagnostic laboratories,
hospital associated labs, and ‘others’. Use of cancer diagnostics
systems was highest in hospital associated labs and independent
diagnostic laboratories. This segment accounted for nearly 43%
revenue share of the market in 2016. Future Market Insights estimates
it to remain the largest end-user throughout the forecast period.
North America is the most lucrative market for cancer diagnostics.
The North America cancer diagnostics market was valued at over US$
12.29 Bn, and it is projected to increase at a CAGR of 9.8% through
2026. The U.S. remains the dominant region for cancer diagnostics in
North America, accounting for over 83% share. Future Market Insights
projects market share of the U.S. to reach 87.1% by 2026.
As is the
case globally, lung cancer is the largest segment by disease
indication in North America as well. This segment accounted for US$
2.43 Bn in 2016, and is projected to grow at 11.7% CAGR throughout
the forecast period. According to Future Market Insights’ research,
elderly population aged 65 and above is more susceptible to lung
cancer due to changing tissue landscape. Diagnosis and confirmation
of lung cancer remains one of the most vexing challenges for
pathologists and clinicians.
Request to sample report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-1090
Summary of Table of Content
1.Executive Summary
2. Market Introduction
3. Global Cancer Diagnostics Market Analysis Scenario
4. Market Dynamics
5.Global Cancer Diagnostics Market Analysis and Forecasts, By Test
Type
6.Global Cancer Diagnostics Market Analysis and Forecasts, By End
User
7.Global Cancer Diagnostics Market Analysis and Forecasts, By
Indication
8.Global Cancer Diagnostics Market Analysis and Forecasts, By
Region
9.North America Cancer Diagnostics Market Analysis and Forecast
10.Latin America Cancer Diagnostics Market Analysis and Forecast
11.Western Europe Cancer Diagnostics Market Analysis and Forecast
12.Eastern Europe Cancer Diagnostics Market Analysis and Forecast
13.APEJ Cancer Diagnostics Market Analysis and Forecast
14.Japan Cancer Diagnostics Market Analysis and Forecast
15.MEA Cancer Diagnostics Market Analysis and Forecast
16.Competition Landscape
17.Assumptions and Acronyms Used
18.Research Methodology
Request to Browse Full Table of Content, figure and Tables@
https://www.futuremarketinsights.com/toc/rep-gb-1090
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email:
sales@futuremarketinsights.com
Website:
www.futuremarketinsights.com
No comments:
Post a Comment